Warning: The NCBI web site requires JavaScript to function. more...
Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.
Roudsari AH, Tahbaz F, Hossein-Nezhad A, Arjmandi B, Larijani B, Kimiagar SM.
Nutr J. 2005 Oct 29;4:30.
Related citations
Soy protein consumption and bone mass in early postmenopausal Chinese women.
Ho SC, Woo J, Lam S, Chen Y, Sham A, Lau J.
Osteoporos Int. 2003 Oct;14(10):835-42. Epub 2003 Aug 14. Review.
Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.
Taku K, Melby MK, Kurzer MS, Mizuno S, Watanabe S, Ishimi Y.
Bone. 2010 Aug;47(2):413-23. Epub 2010 May 7. Review.
One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women.
Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, Arquitt AB, Payton ME, Mason C.
Nutr J. 2005 Feb 23;4:8.
Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.
Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS.
J Clin Endocrinol Metab. 2000 Sep;85(9):3043-8.
Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H; JPOS Study Group.
Osteoporos Int. 2006;17(7):1086-95. Epub 2006 May 3.
Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial.
Ye YB, Tang XY, Verbruggen MA, Su YX.
Eur J Nutr. 2006 Sep;45(6):327-34. Epub 2006 Jun 8.
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P, Delmas PD.
Ann Biol Clin (Paris). 1999 Mar-Apr;57(2):137-48. Review. French.
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.
Clin Ther. 2007 Sep;29(9):1937-49.
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.
Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P.
Maturitas. 2002 Aug 30;42(4):295-300.
Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S, Strickman-Stein N, Doerge DR, Krischer J.
Contemp Clin Trials. 2010 Jul;31(4):293-302. Epub 2010 Mar 15.
Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women.
Scheiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD.
Menopause. 2001 Sep-Oct;8(5):384-92.
Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
Nguyên-Pascal ML, Thomas JL, Bergougnoux L, Garnero P, Drapier-Faure E, Delmas PD.
Climacteric. 2005 Jun;8(2):136-45.
Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
J Obstet Gynaecol Res. 2009 Feb;35(1):152-9.
Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Ravn P, Neugebauer G, Christiansen C.
Bone. 2002 Jan;30(1):320-4.
Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
Chlebna-Sokol D, Rusinska A.
Endocr Regul. 2001 Dec;35(4):201-8.
Effect of soy protein on bone metabolism in postmenopausal Japanese women.
Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H.
Osteoporos Int. 2000;11(8):721-4.
Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys.
Register TC, Jayo MJ, Anthony MS.
J Clin Endocrinol Metab. 2003 Sep;88(9):4362-70.
[Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP, Liao EY, Wu XP, Cao XZ, Shan PF, Su X.
Zhonghua Yi Xue Za Zhi. 2006 Feb 14;86(6):371-5. Chinese.
Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J.
Arch Intern Med. 2011 Aug 8;171(15):1363-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on